Trial
NCT02576457
Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Bristol-Myers Squibb
Collaborators
—
Condition
Severe Sepsis
Intervention
BMS-936559
Why stopped
Business Objectives Have Changed
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-09-15